Market Overview

5 Drug Stores Stocks With The Highest Revenue Estimates

Share:
Related CVS
Morgan Stanley Downgrades CVS Health Amid An 'Increasingly Competitive' PBM Market
The Market In 5 Minutes: Believeland
What The Planned Supermarket Merger Means For Union Bankhares (Seeking Alpha)
Related WAG
Where Are People Using Apple Pay?
Early Global News: Record Online Sales, 400% Jump In Tinder Users, China Experiences Worst Drop In Months

Below are the top drug stores stocks in terms of revenue estimate for the current year.

Analysts expect CVS Caremark (NYSE: CVS) to post revenue of $122.80 billion for the year ending December, 2012. CVS Caremark's trailing-twelve-month revenue is $116.50 billion.

Walgreen Co (NYSE: WAG) is expected to report revenue of $71.73 billion for the year ending August, 2012. Walgreen's trailing-twelve-month revenue is $72.53 billion.

Rite Aid (NYSE: RAD) is likely to post revenue of $25.42 billion in the year ending February, 2013. Rite Aid's trailing-twelve-month revenue is $26.20 billion.

GNC Holdings (NYSE: GNC) may report revenue of $2.43 billion in the year ending December, 2012. GNC Holdings' trailing-twelve-month revenue is $2.29 billion.

PharMerica (NYSE: PMC) is estimated to post revenue of $1.84 billion in the year ending December, 2012. PharMerica's trailing-twelve-month revenue is $1.97 billion.

Posted-In: Drug Stores Industry Highest Revenue EstimatesTrading Ideas

 

Related Articles (CVS + GNC)

View Comments and Join the Discussion!